パーソナル電話,心電図送信機

VOYAGER: an international consortium investigating the role of human papilloma virus and genetics in oral and oropharyngeal cancer risk and survival.

medRxiv : the preprint server for health sciences·2025

Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites.

medRxiv : the preprint server for health sciences·2024

Quality of life, cognitive, physical and emotional function at diagnosis predicts head and neck cancer survival: analysis of cases from the Head and Neck 5000 study.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2020

Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?

Oral oncology·2019

Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability.

Journal of thrombosis and haemostasis : JTH·2017

Mammary analogue secretory carcinoma of the salivary glands: a diagnostic dilemma.

The British journal of oral & maxillofacial surgery·2016

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Ontology-driven energy-efficient SAID framework for 5G and IoT networks using cryptographic techniques.

Scientific reports·2026

Telemedicine: An exploration of global impact and Indian perspectives on healthcare delivery, effectiveness, and challenges.

Journal of family medicine and primary care·2026

Intelligent Congestion Control in the Internet of Vehicles Employing Network Slicing in 5G Architecture.

Sensors (Basel, Switzerland)·2026

Topology Control in Spherical 3D Sensor Networks.

Sensors (Basel, Switzerland)·2026

An Intelligent Energy-Aware Framework for 6G-Enabled Non-Terrestrial IoT via Reinforcement Learning.

Sensors (Basel, Switzerland)·2026

GP-Driven Adaptive Tube MPC for Communication-Preserving Navigation of Mobile Relay Robots in Indoor Disaster Environments.

Sensors (Basel, Switzerland)·2026

関連する実験動画

パーソナル電話,心電図送信機

関連する概念動画

VOYAGER: an international consortium investigating the role of human papilloma virus and genetics in oral and oropharyngeal cancer risk and survival.

Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites.

Quality of life, cognitive, physical and emotional function at diagnosis predicts head and neck cancer survival: analysis of cases from the Head and Neck 5000 study.

Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?

Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability.

Mammary analogue secretory carcinoma of the salivary glands: a diagnostic dilemma.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Ontology-driven energy-efficient SAID framework for 5G and IoT networks using cryptographic techniques.

Telemedicine: An exploration of global impact and Indian perspectives on healthcare delivery, effectiveness, and challenges.

Intelligent Congestion Control in the Internet of Vehicles Employing Network Slicing in 5G Architecture.

Topology Control in Spherical 3D Sensor Networks.

An Intelligent Energy-Aware Framework for 6G-Enabled Non-Terrestrial IoT via Reinforcement Learning.

GP-Driven Adaptive Tube MPC for Communication-Preserving Navigation of Mobile Relay Robots in Indoor Disaster Environments.

関連する実験動画

パーソナル電話,心電図送信機

関連する概念動画

関連記事